Novo Nordisk Pharma GmbH

Industry / private company


Location: Mainz, Germany (DE) DE

ISNI: 0000000405605252

ROR: https://ror.org/03nyzw632

Show on Map:

close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Addition of liraglutide in patients with Type 2 diabetes well controlled on metformin monotherapy improves several markers of vascular function (2012) Forst T, Michelson G, Ratter F, Weber MM, Anders S, Mitry M, Wilhelm B, Pfuetzner A Journal article